These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 10981158)

  • 61. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Quality of life and antihypertensive drug therapy.
    Handler J
    J Clin Hypertens (Greenwich); 2005 May; 7(5):274-85. PubMed ID: 15886530
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Angiotensin II, mechanotransduction, and pulsatile arterial hemodynamics in hypertension.
    Lacolley P; Safar ME; Regnault V; Frohlich ED
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1567-75. PubMed ID: 19734358
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension.
    Levi-Marpillat N; Macquin-Mavier I; Tropeano AI; Parati G; Maison P
    Hypertens Res; 2014 Jun; 37(6):585-90. PubMed ID: 24671016
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Continuous improvement of arterial compliance beyond blood pressure decrease after 5 years of antihypertensive treatment.
    Bellido CA; Iavicoli OR; Rusak EJ; Vazquez ST; Piñeiro DJ; Lerman J
    J Clin Hypertens (Greenwich); 2006 Aug; 8(8):555-60. PubMed ID: 16896271
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Angiotensin converting enzyme inhibition in clinical practice. A re-examination of stepped-care: a retrospective and a prospective.
    Zanchetti A
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S126-31. PubMed ID: 2580166
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Established blood pressure drug wins out in a comparative study. In hypertension, a diuretic first!].
    Wepner U
    MMW Fortschr Med; 2003 Jan; 145(1-2):10-2. PubMed ID: 12638431
    [No Abstract]   [Full Text] [Related]  

  • 68. Intraclass differences among antihypertensive drugs.
    Feldman RD; Hussain Y; Kuyper LM; McAlister FA; Padwal RS; Tobe SW
    Annu Rev Pharmacol Toxicol; 2015; 55():333-52. PubMed ID: 25251994
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of blood pressure-lowering on outcome incidence in hypertension: 5. Head-to-head comparisons of various classes of antihypertensive drugs - overview and meta-analyses.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2015 Jul; 33(7):1321-41. PubMed ID: 26039526
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A rational approach to the treatment of hypertension in special populations.
    Hall WD
    Am Fam Physician; 1999 Jul; 60(1):156-62. PubMed ID: 10414635
    [TBL] [Abstract][Full Text] [Related]  

  • 72. ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension.
    Morgan TO; Anderson AI; MacInnis RJ
    Am J Hypertens; 2001 Mar; 14(3):241-7. PubMed ID: 11281235
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive Patients.
    Brook RD; Kaciroti N; Bakris G; Dahlöf B; Pitt B; Velazquez E; Weber M; Zappe DH; Hau T; Jamerson KA
    J Am Heart Assoc; 2018 Jan; 7(1):. PubMed ID: 29301757
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Antihypertensive therapy in 357 inpatients of elderly isolated systolic hypertension].
    Zhai LH; Yang CY; Jiang KW; Xu XY; Lu HZ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):719-22, 725. PubMed ID: 16708819
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug?
    Wright JM; Lee CH; Chambers GK
    CMAJ; 1999 Jul; 161(1):25-32. PubMed ID: 10420860
    [No Abstract]   [Full Text] [Related]  

  • 76. Can antihypertensive treatment reverse large-artery stiffening?
    Safar ME
    Curr Hypertens Rep; 2010 Feb; 12(1):47-51. PubMed ID: 20425158
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antihypertensive drug therapies and the risk of ischemic stroke.
    Klungel OH; Heckbert SR; Longstreth WT; Furberg CD; Kaplan RC; Smith NL; Lemaitre RN; Leufkens HG; de Boer A; Psaty BM
    Arch Intern Med; 2001 Jan; 161(1):37-43. PubMed ID: 11146696
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prescribing patterns and therapeutic implications for diabetic hypertension in Bahrain.
    Al Khaja KA; Sequeira RP; Mathur VS
    Ann Pharmacother; 2001 Nov; 35(11):1350-9. PubMed ID: 11724081
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The role of fixed-dose combination therapy with drugs that target the renin-angiotensin system in the hypertension paradigm.
    Schmieder RE
    Clin Exp Hypertens; 2010 Jan; 32(1):35-42. PubMed ID: 20144071
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Diastolic pressure, systolic pressure, or pulse pressure?
    Vlachopoulos C; O'Rourke M
    Curr Hypertens Rep; 2000 Jun; 2(3):271-9. PubMed ID: 10981160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.